Lakefront Biotherapeutics (LKFT) Tax Provisions (2014 - 2026)

Lakefront Biotherapeutics (LKFT) has 11 years of Tax Provisions data on file, last reported at -$81952.2 in Q1 2026.

• On a quarterly basis, Tax Provisions fell 104.29% year-over-year to -$81952.2 in Q1 2026; TTM through Mar 2026 was -$23.7 million, a 871.9% decrease from a year earlier, with the FY2025 full-year figure at -$21.7 million, down 1025.03% from the prior year.
• Tax Provisions for Q1 2026 stood at -$81952.2, up from -$44.1 million in the prior quarter.
• Over the last five years, Tax Provisions for LKFT reached as high as $23.2 million in Q3 2025 and fell as low as -$44.1 million in Q4 2025.
• Historically, Tax Provisions has averaged -$2.1 million across 5 years, with a median of -$106859.5 in 2024.
• On a YoY basis, Tax Provisions climbed as much as 1066.89% in 2025 and fell as far as 41193.98% in 2025.
• Year by year, Tax Provisions stood at $3.9 million in 2022, then plunged by 158.26% to -$2.3 million in 2023, then jumped by 95.27% to -$106859.5 in 2024, then plunged by 41193.98% to -$44.1 million in 2025, then surged by 99.81% to -$81952.2 in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were -$81952.2 in Q1 2026, -$44.1 million in Q4 2025, and $23.2 million in Q3 2025.